Dermatopathology and Histology Examination
Microscopic examination of skin biopsy specimens by dermatopathologists, integrating clinical history, gross morphology, hematoxylin-eosin (H&E) histopathology, immunohistochemistry, direct immunofluorescence, and molecular studies to diagnose inflammatory dermatoses, neoplasms, infections, and genetic skin disorders.
This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.
This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →
What is Dermatopathology and Histology Examination?
Dermatopathology is a subspecialty of pathology and dermatology that focuses on the microscopic diagnosis of skin diseases. Dermatopathologists are physicians trained in both pathology and dermatology, holding board certification in dermatopathology after completion of pathology or dermatology residency. The diagnostic process begins with a skin biopsy obtained by various techniques: (1) Shave biopsy: scalpel or razor blade removes superficial portion, suitable for elevated lesions like seborrheic keratosis or basal cell carcinoma, but inadequate for deep or pigmented lesions. (2) Punch biopsy: cylindrical punch (2-8 mm typically) removes full-thickness skin including subcutaneous fat, standard for inflammatory dermatoses and most diagnostic biopsies. (3) Incisional biopsy: scalpel removes wedge from larger lesion for diagnosis without complete excision. (4) Excisional biopsy: complete removal of lesion with margin, used for definitive treatment of suspected melanoma or for complete diagnosis. The specimen is placed in 10% buffered formalin for fixation, then processed (dehydration in graded alcohols, xylene clearing, paraffin embedding), sectioned at 4-5 micrometers thickness on a microtome, mounted on glass slides, deparaffinized, and stained.
Standard staining and special stains: hematoxylin and eosin (H&E) is the routine stain — hematoxylin stains nuclei blue/purple, eosin stains cytoplasm and extracellular matrix pink. Special stains as needed: Periodic acid-Schiff (PAS) with diastase for fungi (highlights cell walls), Gram stain for bacteria (gram-positive blue, gram-negative red), Acid-fast (Ziehl-Neelsen, Fite) for mycobacteria, Giemsa for mast cells and Leishmania amastigotes, Verhoeff-van Gieson for elastic fibers (anetoderma, mid-dermal elastolysis, pseudoxanthoma elasticum), Congo red for amyloid (apple-green birefringence under polarized light), Alcian blue for mucin (lupus, granuloma annulare, scleromyxedema), Fontana-Masson for melanin, Perls (Prussian blue) for iron (hemosiderin), Masson trichrome for collagen and muscle. Immunohistochemistry (IHC) uses antibodies linked to enzymes (peroxidase) or fluorochromes to detect specific antigens: cytokeratin panel (CK7, CK20, CK5/6) for epithelial origin and primary site, S100 and SOX10 for melanocytes and Schwann cells, MART-1/Melan-A and HMB-45 for melanocytes, vimentin for mesenchymal cells, CD3 for T cells (CD4 helper, CD8 cytotoxic), CD20 for B cells, CD30 for activated lymphocytes (lymphomatoid papulosis, anaplastic large cell lymphoma), CD117/c-KIT for mast cells, CD1a for Langerhans cells, factor XIIIa for dendrocytes, EMA for epithelial membrane antigen, BerEP4 for basal cell carcinoma differentiating from squamous cell, p63 for myoepithelial cells. Direct immunofluorescence (DIF) on perilesional skin biopsy is critical for autoimmune bullous diseases (pemphigus vulgaris — IgG and C3 in intercellular pattern; bullous pemphigoid — IgG and C3 linear at basement membrane zone; dermatitis herpetiformis — granular IgA at dermal papillae; linear IgA bullous dermatosis — linear IgA at basement membrane), lupus (granular IgG, IgM, C3 at dermo-epidermal junction in lupus band test), vasculitis (immune complex deposits in vessel walls).
Dermatopathology diagnostic patterns and approach: dermatopathologists use systematic pattern recognition. Inflammatory dermatoses are categorized by reaction patterns: (1) Spongiotic: intraepidermal edema with eczematous appearance (atopic, contact, nummular, dyshidrotic eczema, pityriasis rosea, viral exanthems). (2) Psoriasiform: regular acanthosis with elongated rete ridges (psoriasis, lichen simplex chronicus, chronic eczema, mycosis fungoides plaque stage). (3) Interface/lichenoid: vacuolar degeneration of basal layer with lymphocytic infiltrate at dermo-epidermal junction (lichen planus, lichenoid drug eruption, lupus, lichen sclerosus, erythema multiforme). (4) Vesiculobullous: subepidermal or intraepidermal blisters (pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis, friction blister, EB). (5) Granulomatous: collections of histiocytes with or without giant cells (sarcoidosis, granuloma annulare, necrobiosis lipoidica, foreign body, mycobacterial). (6) Vasculitic: inflammation of vessel walls with fibrinoid necrosis (leukocytoclastic vasculitis, polyarteritis nodosa, ANCA-associated vasculitis). (7) Panniculitic: inflammation of subcutaneous fat (erythema nodosum septal panniculitis, lupus panniculitis lobular). (8) Folliculitis/Perifolliculitis. Neoplasms: dermatopathologist evaluates architecture (symmetry, circumscription), cytology (cell type, atypia, mitoses), tumor cell relationship to epidermis (lentiginous melanoma, pagetoid melanoma), depth of invasion (Breslow thickness for melanoma, Clark level), perineural and lymphovascular invasion, and surgical margins. Special challenges: distinguishing benign from malignant melanocytic lesions (Spitz nevus, dysplastic nevus, melanoma), early diagnosis of mycosis fungoides (epidermotropism, atypia, T-cell receptor clonality), and distinguishing reactive from neoplastic lymphoid infiltrates. Final dermatopathology report should include clinical history, microscopic description, special stain results, immunohistochemistry, molecular studies if performed, and final integrated diagnosis with comments on differential diagnosis and recommendations for further workup or treatment.
Symptoms
Risk Factors
When to See a Doctor?
If you experience any of the following symptoms, seek medical attention promptly:
- Suspicious skin lesion (asymmetric, irregular, color variation, growing, bleeding)
- Persistent rash not responding to standard therapy
- New blistering disease
- Sudden severe drug reaction
- Worsening or atypical mole
- Non-healing skin ulcer or crusted lesion
- Indurated, painful, or rapidly growing skin nodule
- Family history of melanoma with suspicious lesion
Treatment Methods
Which Department to Visit?
You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.
Learn About Dermatoloji DepartmentLet us help you
You can make an appointment with our specialists or contact us for your concerns.
Related Health Topics
Other articles from the same department you may want to explore.
Eczema (Atopic Dermatitis)
Dermatoloji
Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.
Psoriasis
Dermatoloji
Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.
Acne
Dermatoloji
Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.
Rosacea
Dermatoloji
Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.
Urticaria (Hives)
Dermatoloji
Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.
Skin Fungal Infections
Dermatoloji
Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.
Hair Loss (Alopecia)
Dermatoloji
Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.
Vitiligo
Dermatoloji
Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.
Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.